1. Design, synthesis, and testing of an isoquinoline-3-carboxylic–based novel anti-tumor lead. Fei Gao, Haiqing Liu , Li Li, Jianpeng Guo,Yuji Wang, Ming Zhao, Shiqi Peng. Bioorg. Med. Chem. Lett. 2015, 4434–4436.
2. Self-complexation and complexation-controlled target cancer therapy. Li Li, Ming Zhao, Wenhao Li, Yuji Wang, Zhuge Zhang, Ran An, Shiqi Peng, MedChemComm. 2012, 1059-1061.
3. pH-Dependent nanostructure based on isoquinoline-cyclodextrin conjugate for thrombosis therapy. Li Li, Ming Zhao, Wenhao Li, Yuji Wang, Chunna Liu, Zhuge Zhang, Songchun Su, Shiqi Peng, Nanomed-Techl. 2012, 8, 1216-1222.